
A new clinical trial shows adding a targeted breast cancer drug to hormonal therapy reduced the risk of cancer returning by 25% for women with early-stage disease.
https://ift.tt/3eLMRYs
from WebMD Health https://ift.tt/GVsWlIH
by
A new clinical trial shows adding a targeted breast cancer drug to hormonal therapy reduced the risk of cancer returning by 25% for women with early-stage disease.
Comments
Post a Comment